Batimastat (INN/USAN codenamed BB-94) is an anticancer drug that belongs to the family of drugs called angiogenesis inhibitors. It acts as a matrix metalloproteinase inhibitor (MMPI) by mimicking natural MMPI peptides.Batimastat was the first MMPI that went into clinical trials. First results of a Phase I trial appeared in 1994.
This page contains content from the copyrighted Wikipedia article "Batimastat"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
